Shares of Globe Life Inc. (NYSE:GL - Get Free Report) have earned a consensus rating of "Moderate Buy" from the eleven analysts that are currently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $191.6667.
Several research analysts have weighed in on GL shares. Morgan Stanley upped their target price on Globe Life from $181.00 to $208.00 and gave the stock an "overweight" rating in a research report on Monday, July 6th. Jefferies Financial Group boosted their price target on Globe Life from $147.00 to $166.00 and gave the company a "hold" rating in a research note on Friday, July 10th. Weiss Ratings downgraded Globe Life from a "buy (b)" rating to a "buy (b-)" rating in a report on Monday, July 20th. TD Cowen raised their price objective on shares of Globe Life from $215.00 to $225.00 and gave the company a "buy" rating in a research report on Wednesday, July 22nd. Finally, Wells Fargo & Company boosted their target price on shares of Globe Life from $172.00 to $193.00 and gave the stock an "overweight" rating in a research report on Thursday, July 9th.
View Our Latest Analysis on Globe Life
Globe Life Trading Down 0.1%
Shares of NYSE:GL opened at $173.09 on Thursday. The firm has a fifty day moving average of $177.47 and a two-hundred day moving average of $162.28. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life has a 12-month low of $127.85 and a 12-month high of $191.55. The firm has a market capitalization of $13.30 billion, a P/E ratio of 11.49 and a beta of 0.46.
Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). The firm had revenue of $1.60 billion for the quarter, compared to analysts' expectations of $1.59 billion. Globe Life had a return on equity of 20.52% and a net margin of 19.58%.Globe Life's revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, equities analysts expect that Globe Life will post 15.71 EPS for the current fiscal year.
Globe Life declared that its Board of Directors has approved a stock repurchase program on Monday, August 10th that permits the company to repurchase $2.50 billion in outstanding shares. This repurchase authorization permits the company to buy up to 17.7% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board of directors believes its stock is undervalued.
Globe Life Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.8%. The ex-dividend date is Monday, October 5th. Globe Life's dividend payout ratio (DPR) is 8.76%.
Insiders Place Their Bets
In related news, EVP Michael Majors sold 37,000 shares of the company's stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total value of $6,609,680.00. Following the sale, the executive vice president owned 53,518 shares of the company's stock, valued at $9,560,455.52. The trade was a 40.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO James Darden sold 50,000 shares of Globe Life stock in a transaction on Friday, July 31st. The shares were sold at an average price of $182.43, for a total value of $9,121,500.00. Following the transaction, the chief executive officer directly owned 58,451 shares of the company's stock, valued at approximately $10,663,215.93. The trade was a 46.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 141,908 shares of company stock worth $25,573,181 over the last quarter. 2.11% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Globe Life
Hedge funds and other institutional investors have recently made changes to their positions in the company. Hilton Head Capital Partners LLC acquired a new stake in shares of Globe Life in the 4th quarter valued at approximately $30,000. Johnson Financial Group Inc. acquired a new position in Globe Life during the second quarter valued at approximately $39,000. AdvisorNet Financial Inc grew its holdings in Globe Life by 41.1% during the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company's stock valued at $44,000 after purchasing an additional 92 shares during the period. Root Financial Partners LLC increased its stake in Globe Life by 23.3% in the first quarter. Root Financial Partners LLC now owns 439 shares of the company's stock valued at $61,000 after purchasing an additional 83 shares in the last quarter. Finally, Assetmark Inc. increased its stake in Globe Life by 42.0% in the second quarter. Assetmark Inc. now owns 426 shares of the company's stock valued at $76,000 after purchasing an additional 126 shares in the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.
About Globe Life
(
Get Free Report)
Globe Life Inc is an insurance holding company headquartered in McKinney, Texas. Through its subsidiaries, the company markets and distributes individual life insurance and supplemental health insurance products to middle-income households and other consumer segments.
Its product offerings include term and whole life insurance, mortgage protection and final expense coverage, accident and supplemental health insurance, Medicare supplement policies, and annuity products. Globe Life distributes these products through multiple channels, including direct-to-consumer marketing, agency networks, and independent agents.
The company's principal insurance businesses include Globe Life and Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, United American Insurance Company, and Family Heritage Life Insurance Company of America.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.